A Phase II Study of Lapatinib for Brain Metastases in Subjects with ErbB2-Positive Breast Cancer Following Trastuzumab based Systemic Therapy and Cranial Radiotherapy

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
This article has no abstract
Epistemonikos ID: e51b0172dd8ab866583c62abd29b5b43491b8c55
First added on: Apr 17, 2025